Leadership

Executive Team/Board of Directors


Gregory C. Marotta

President and CEO, CleanSlate Centers

Gregory Marotta oversees the strategic and daily operational leadership of CleanSlate. With his extensive experience in leadership roles in the healthcare field, Gregory is an invaluable leader as CleanSlate continues to expand across the nation to combat the mounting opioid epidemic.

Prior to joining CleanSlate, Gregory was the Senior Vice President of National Operations at U.S. Healthworks, where he oversaw a national network of over 230 healthcare facilities in 20 states. Before acting in this national position at U.S. Healthworks, Marotta worked as Senior Vice President of Operations in the east division and as Vice President of Operations at the company. Earlier in his career, Gregory served as Vice President of Outpatient Services at the Kessler Institute for Rehabilitation.

Gregory obtained his Bachelor of Arts degree from Kean University and is a graduate of the Advanced Management Program at Harvard Business School.

Anthony Belott

Chief Development Officer, CleanSlate Centers

Anthony brings 15 years of Healthcare Corporate and Business Development expertise to CleanSlate Centers. As Chief Development Officer, Anthony is responsible for establishing and fostering key external partnerships and alliances that will aid CleanSlate’s efforts to successfully enter new markets and expand the company’s presence nationwide.

Before joining CleanSlate, Anthony served as Senior Vice President of Business Development for DSI Renal where he worked as co-head of Business Development for the fifth-largest for-profit operator of outpatient dialysis clinics in the U.S. Prior to his position at DSI, Anthony served as Vice President of Business Development for U.S. HealthWorks, leading the expansion of the second-largest operator of occupational medicine and urgent care clinics in the U.S. Anthony successfully negotiated and closed 20 transactions yielding 48 acquired clinics, growing U.S. HealthWorks to more than 200 medical clinics and worksites in 19 states.

Anthony earned his B.S. in Economics from the Wharton School of the University of Pennsylvania and his M.B.A. in Finance from the U.C.L.A. Anderson School of Management.

Paul Chabot

Chief Information Officer, CleanSlate Centers

At CleanSlate, Paul has assembled scalable, reliable, and secure technology platforms that have enabled exponential growth.  With over twenty years in the IT field, Paul has held numerous technology leadership positions, including four CIO roles. His breadth of experience ranges from startup firms to Fortune 50 health care organizations within a variety of industries, such as: insurance and pharmacy benefit management, third party administration, and multi-clinic provider organizations.

Prior to joining CleanSlate, Paul held the position of CIO of FastMed Urgent Care, where he created an IT team and forged technology partnerships that allowed the company to grow tenfold in four years. At Aetna, Chabot was the IT lead in the pharmacy benefit division, managing hundreds of staff and consultants for the program’s application development. Prior to this position, Chabot acted as CIO at Evolution1, where he developed patented technology for the HSA and FSA debit card industry. Earlier in his career, as CIO of Women’s Health USA, Paul constructed the company’s first centralized EMR/Billing system.

Kelly J. Clark, MD, MBA, DFAPA, FASAM

Chief Medical Officer, CleanSlate Centers
President, American Society of Addiction Medicine

Dr. Clark has served as President of ASAM since April, 2017. Representing over 4,000 physicians specializing in Addiction Medicine and over 150 associated professionals, ASAM is the largest group of physicians and allied health professions specializing in treating addictive diseases. As the Chief Medical Officer of CleanSlate Centers, she provides clinical and sector expertise in addiction medicine for strategic planning, clinical program development, and quality improvement. Dr. Clark is responsible for leadership and oversight of medical staff and clinical guidelines for program services, and establishing and maintaining collaborative relationships with external stakeholder groups at the state and national levels.

Dr. Clark’s expertise in health care delivery systems and financing is built upon her vast breadth of clinical work, including emergency, acute, sub-acute, and chronic institutions; community, county, state, federal sites; voluntary; involuntary and penal settings. She served as faculty of the UMass Medical School for eight years training students and resident physicians on the inpatient dual diagnosis unit as well as in outpatient, partial hospital, and consultative settings. She is currently a member of the Integrated Care Work Group of the American Psychiatric Association; SAMHSA Expert Committee on Opioid Treatment Program Guidelines; the National Rx Drug Abuse Summit Advisory Board; and the faculty of the Virginia Tech Carilion School of Medicine.

In addition, Dr. Clark holds an MBA with Additional Certification in Health Sector Management. She is Board Certified in Psychiatry by American Board of Psychiatry and Neurology, as well as Board Certified in Addiction Medicine by the American Board of Addiction Medicine.

Patrick Murphy

Chief Financial Officer, CleanSlate Centers

As CFO, Patrick’s efforts ensure that CleanSlate remains financially efficient while continuing to provide the highest quality care in addiction treatment. Patrick oversees all areas of finance, billing, and risk management; all essential and important tasks as CleanSlate continues its national expansion. Patrick possesses an extensive background in both financial and operational leadership positions, and has been highly involved with health care and high growth organizations.

Before joining CleanSlate, Patrick was Co-Founder of Women’s Health USA, which provides business and strategic services to physicians in women’s healthcare. Patrick held several positions at this national company including CFO, COO, and President. Murphy was also a Founder and Executive Vice President of Evolution1, one of the nation’s largest healthcare solutions companies. Earlier in his career, Patrick gained ten years of experience in the insurance and financial service industries at Arthur Andersen. He is a Certified Public Accountant and serves as a member of the Connecticut Society of Certified Public Accountants.

Amanda Wilson, MD

Chairwoman of the Board and Founder, CleanSlate Centers

In response to the growing opioid epidemic facing the country, Dr. Wilson founded CleanSlate in 2009 with the mission of providing high quality medical care and improved access for the underserved population of patients seeking addiction treatment.

Dr. Wilson received her medical degree from the University of Vermont, College of Medicine. She completed residency and Chief Residency in internal medicine at Baystate Medical Center in Springfield, Massachusetts. Prior to founding CleanSlate, Dr. Wilson was the Medical Director of Mercy Medical Center’s hospitalist program, in Springfield, MA and served as Chief of Medicine and chair of the Center’s Peer Review.

Dr. Wilson’s outreach and education efforts include participation in various groups focused on addiction and high-risk patients, including those responding to the need for increased access to the appropriate continuum of care for opioid dependent patients. She provides frequent group presentations to physicians and other care providers within private practice, hospitals, and other clinical settings on the epidemic nature of opioid dependence and the pharmacology of buprenorphine treatment.

Paul F. Brown

Board Member

Paul Brown teaches classes in entrepreneurship, innovation, the foundations of business thought, and business law. He holds the position of the James Lee Sorenson Presidential Endowed Chair at the University of Utah’s David Eccles School of Business. Prior to teaching, Paul was a Managing Director at Sandbox Industries, designing and raising the capital for a three hundred million dollar healthcare-oriented venture capital fund. He also was the founder and CEO of Sandbox’s innovation consulting practice, which connected Fortune 500 companies with strategically relevant, innovative startups. Earlier in his career, Paul was a senior executive with Blue Cross Blue Shield, both as Vice President & Deputy General Counsel, and as Vice President of Venturing.  Paul obtained his JD from the Northwestern University School of Law and holds dual BAs in Philosophy and Political Science from the University of Utah. In addition to serving as a CleanSlate director, Paul currently serves as a director of AMP Media Services, is an advisor to GBS Healthcare/Advantia and Braeburn Pharmaceuticals.

Diane M. Daych

Partner, Apple Tree Partners
Board Member

Diane has over 25 years of investing, advisory and operating experience, with 20 years focused on the healthcare services industry. She joined Apple Tree Partners in 2013 to lead their healthcare services investing. From 2010 to 2012, she was a Managing Director and Co-Head, Private Equity of the Marwood Group. Additionally, since 2000, Diane has been a partner and principal at CCP Equity Partners (“CCP”) and its predecessor firm, Conning Capital Partners, where she invested in growth companies that offer specialized solutions for the financing, management and delivery of health care in industries such as managed care, disease and care management, outpatient services, information technology and healthcare-related ancillary and outsourcing services. Prior to joining CCP in 2000, she held a senior development role at Mariner Health, a post acute care company, where she worked with operating management to develop the strategies and structures for physician practice management acquisitions and joint ventures. Prior to Mariner, Diane held senior operating roles at Medical Care America (MCA), one of the largest operators of free standing ambulatory surgery centers at that time.

Diane currently sits on the Board of Directors of TripleCare (formerly eSNF Patient Care), CleanSlate Addiction Treatment Centers, Prism Education Group, the Tuck School’s MBA Advisory Board, The Healthcare Private Equity Associat9ion (HCPEA) and the Women’s Association of Venture and Equity (WAVE). She was previously on the Board of Directors of Cogent Healthcare, Relay Health, Zoologic, and an observer for Evolution Benefits and Vantage Oncology. She is a past president of the Hartford Chapter of the Connecticut Venture Group and sat on its statewide board for several years. She received an MBA from the Tuck School at Dartmouth College and a BA in Economics from Lehigh University.

Eugene C. Fleming

Board Member

Gene Fleming is Chairman of Dermatology Solutions Group and serves on the Board of Directors for Aspire Health, Syus Inc., as well as CleanSlate Addiction Treatment Centers. A lifelong healthcare executive, Fleming most recently served as Executive Chairman of the Rehab Documentation Company until its purchase in May 2014 and on the board of PhyMed Holdings until its acquisition in November 2014. He was Chairman and CEO of Cogent Healthcare from 2005 until its acquisition in 2011. Prior to Cogent, he held several executive management roles, including President and CEO of Surgical Alliance Corporation until its sale in 2005, and Executive Vice President and COO of Quorom Healthcare. Fleming moved to Nashville, TN in 1993 to serve as President of the Eastern Group, a three billion dollar division of Hospital Corporation of America. He previously served as CEO of three HCA hospitals. He is a retired Fellow of the American College of Healthcare Executives, served on the Boards of the Florida Hospital Association, the Federation of American Hospitals, the Regional Policy Board of the American Hospital Association, and as Chairman of the Florida League of Hospitals.

Seth Harrison

Board Member

Seth Harrison is the founder and managing partner of Apple Tree Partners.  He has invested in life sciences since 1991.  He is currently Chairman of ATP companies Braeburn Pharmaceuticals, Cure Forward, Elstar Therapeutics, Limelight Bio, Stoke Therapeutics, and Syntimmune, and is a Director of CleanSlate Addiction Treatment Centers and Corvidia Therapeutics.

Seth’s prior investments include: Aileron Therapeutics, ArQule, Coelacanth, Cyrano Sciences, Gloucester Pharmaceuticals, HeartWare International, Informed Access, SGX Pharmaceuticals, Tokai Pharmaceuticals, Ultracision, and ViroPharma.  From 2002 to 2010, he also served on the board of the International Partnership for Microbicides.  Prior to founding ATP in 1999, Seth was a general partner at Oak Investment Partners, and before that a venture partner at Sevin Rosen Funds.

Seth received an A.B. from Princeton University, an MD and MBA both from Columbia University and completed a surgery internship at the Presbyterian Hospital in the City of New York.

Christopher M. Jedrey

Board Member

Chris is a partner in the law firm of McDermott Will & Emery LLP, based in the Firm’s Boston office.  He is partner-in-charge of its Boston Health Industry Advisory Practice Group, and national co-chairman of its Academic Medical Centers practice. Chris represents nonprofit and for-profit health care provider and health plan clients in merger, acquisition, affiliation, and joint venture transactions; sales of non-profit assets and operations to for-profit companies; and conversions from taxable to tax-exempt status. He represents academic medical centers for a variety of matters, including strategic affiliations, clinical research issues and faculty practice plan structures. Chris’ notable projects include: advising Caritas Christi, a six-hospital non-profit Catholic system, on the sale of its assets and operations to private-equity-funded Steward Health Care System, and advising the buyer on several subsequent hospital and large group practice acquisitions; advising Maimonides Medical Center on its affiliation with Northwell Health (formerly North Shore-Long Island Jewish Health System); representing Hartford HealthCare in establishing a clinical and research affiliation with Memorial Sloan-Kettering Cancer Center; and providing corporate, regulatory and tax advice on the formation and ongoing operations of Dana-Farber/Brigham and Women’s Cancer Center, most recently with respect to its development of a network of community-based satellite clinics and other clinical partnerships. Chris has been given the highest ranking in health care nationally and in Massachusetts by Chambers USA 2015 as a transactional lawyer. He has an undergraduate degree from the University of Massachusetts-Amherst, a Ph.D. from Harvard University and J.D. from Boston College Law School.

Patrick J. Kennedy

Board Member

Patrick J. Kennedy is the nation’s leading political voice on mental illness, addiction, and other brain diseases.  While representing Rhode Island in Congress, he fought a national battle to end medical and societal discrimination against these illnesses.

Since leaving Congress to devote himself to brain advocacy, he founded The Kennedy Forum, which provides leadership in the mental health community, and co-founded One Mind, a global leader in open science.  He co-authored “A Common Struggle,” which outlines both his personal story and a bold plan for mental health in America.

Patrick lives in New Jersey with his wife, Amy, and their four children.

Dan Kossmann

Board Member

With over 35 years of experience providing financial leadership to growth companies, Dan brings extensive knowledge of complex accounting, funding strategies, financial analysis and reporting, strategic planning, IPO’s and M&A transactions to CleanSlate. Dan has been responsible for building the financial infrastructures and providing the financial management to achieve profitability and enable growth. He has also successfully completed an IPO, managed sales to strategic buyers, completed multiple domestic and cross border acquisitions, and raised hundreds of millions of dollars in debt and equity capital. Dan is a Certified Public Accountant and holds a Bachelor of Science in Business Administration with a concentration in Accounting from Niagara University.